Viewing StudyNCT00023881



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00023881
Status: TERMINATED
Last Update Posted: 2018-11-14
First Post: 2001-09-13

Brief Title: Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Organization Data

Organization: MD Anderson Cancer Center
Class: OTHER
Study ID: CDR0000068872
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH